Qube Research & Technologies Ltd - CYCLO THERAPEUTICS INC ownership

CYCLO THERAPEUTICS INC's ticker is CYTH and the CUSIP is 23254X201. A total of 22 filers reported holding CYCLO THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 5.4%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of CYCLO THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$27
-6.9%
210.0%0.00%
Q1 2024$29
-84.9%
21
-82.6%
0.00%
Q4 2023$1921210.00%
Other shareholders
CYCLO THERAPEUTICS INC shareholders Q1 2024
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 603,000$506,5800.01%
VANGUARD GROUP INC 253,882$213,2860.00%
FMR LLC 600$5040.00%
WELLS FARGO & COMPANY/MN 2,311$1,9410.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 1,640$1,3780.00%
IFP Advisors, Inc 13$550.00%
OSAIC HOLDINGS, INC. 600$5040.00%
Princeton Global Asset Management LLC 300$2520.00%
GEODE CAPITAL MANAGEMENT, LLC 52,253$43,9440.00%
View complete list of CYCLO THERAPEUTICS INC shareholders